Oct
2026
Fiera Milano, Italy
Visit us
stand 16A66, Finished Dosage & Formulation

Liaoning Cheng Da Biotechnology Co., Ltd

Exhibitor at CPHI Milan 2026
About Us

Liaoning Cheng Da Biotechnology Co Ltd is a biotech company that focuses on the R&D, manufacturing, sales and marketing of vaccines in China and the international market. Our major products includes: chromatographically purified rabies vaccine for human use (Vero cell); 400 million doses sold in more than 30 countries without any immunization failure; inactivated Japanese encephalitis vaccine for human use (Vero cell); new generation of "Green" vaccine free of preservative, adjuvant and antibiotics; and a number of vaccines under pipeline or to be on market in the near further.

  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    1
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Technology
Contact info
  • No. 1 Xinfang Street, Hunnan New District,, 110179, Shenyang , China
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 16A66, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • Japanese encephalitis vaccine for human use

    Product Japanese encephalitis vaccine for human use

    Liaoning cheng da biotechnology co ltd offers a vaccine technology which includes japanese encephalitis vaccine for human use. It is a freeze-dried or liquid preparation and produced from the japanese encephalitis strain-p3 strain based on continuous vero cells culture. It is used for the prevention of ...
  • Rabies vaccine for human use

    Product Rabies vaccine for human use

    Liaoning cheng da biotechnology co ltd offers a vaccine technology which includes rabies vaccine for human use. It is a freeze-dried or liquid preparation and produced from the fixed rabies virus strain of pv-2061 (pasteur virus strain, recommended by who) based on continuous vero cells culture. It is a...